Printer Friendly
The Free Library
5,677,417 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Webcast Alert: Biomira Inc. Presentation at Informed Investors Biotechnology/Cancer Stocks Virtual Forum to be Webcast on Thursday, November 4, 2004, 10:00 am ET.


RICHMOND, Va. -- Informed Investors Forums announces the presentation of Biomira Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: BIOM BIOM Biomira Inc. (stock symbol)
BIOM Biometrisches Merkmal (biometrics) 
) (TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
: BRA) at the following forum:
What: Biomira Inc. (NASDAQ: BIOM) (TSX: BRA) will give a
      presentation at Informed Investors Biotechnology/Cancer
      Stocks Virtual Forum.

Ronald Garren, M.D., Board Certified Internist and Editor of
      Biotech Insight, will deliver the forum keynote at 9 am.

When: November 4, 2004 @ 10:00 AM Eastern Time

Where: http://www.informedinvestors.com/IIF_Forum.asp?ForumID=85130

How: Live over the Internet--Simply log on to the web at the
     address above.

Contact: Jane Tulloch, Director, Investor Relations,
     jtulloch@biomira.com


If you are unable to attend the live event, the forum will be available via webcast at http://www.informedinvestors.com/IIF_Forum.asp?ForumID=85130.

Biomira Inc. is a biotechnology company applying its leading technology in immunotherapy Immunotherapy

The treatment of cancer by improving the ability of a tumor-bearing individual (the host) to reject the tumor immunologically. There are molecules on the surface of tumor cells, and perhaps in their interior, that are recognized as different from
 and organic chemistry for the development of cancer therapeutics. The Company's commitment to the development of products for the treatment of cancer is currently focused on synthetic therapeutic vaccines therapeutic vaccine Immunology A vaccine–eg, Salk's Remune intended to treat a viral infection by stimulating the immune system. See Vaccine therapy.  and innovative strategies for immunotherapeutic treatment of cancer.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Nov 2, 2004
Words:175
Previous Article:ManTech Awarded Five-Year, $19.3 Million Information Management/Information Technology Services Contract to Support Brooke Army Medical Center.
Next Article:Quest Software Unveils New Product for Group Policy Management.
Topics:



Related Articles
String of Announcements Caps Wacky 1998 for Biotech Investors.
ADVISORY/Biomira Inc. Annual General Meeting; Biomira to Highlight Merck KGaA Co-Promotion Collaboration At Annual General Meeting.
Repligen, CareScience, Neff, and Vitran Events to be Broadcast by Vcall Over the Internet.
Corixa to Participate at Needham & Company Biotechnology Conference.
Webcast Alert: Viragen, Inc. Presentation at Informed Investors Biotechnology/Cancer Stocks Virtual Forum to be Webcast on Thursday, November 4,...
Webcast Alert: Genetronics Biomedical Corporation Presentation at Informed Investors Biotechnology/Cancer Stocks Virtual Forum to be Webcast on...
Webcast Alert: MycoBiotech Inc. Presentation at Informed Investors Biotechnology/Cancer Stocks Virtual Forum to be Webcast on Thursday, November 4,...
Webcast Alert: Baytex Energy Trust Presentation at Informed Investors Canadian Energy Trust Virtual Forum to be Webcast on Tuesday, November 16,...
Seattle Genetics to Present at Two Upcoming Investor Conferences.
Investors to Hear from over 10 Companies at Biotechnology & Healthcare Investor Forum in San Francisco on December 7.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles